Targeting Aß oligomers a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease
Main Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
London
Henry Stewart Talks
2014, 2014
|
Series: | Drug discovery and development in the neurosciences
|
Subjects: | |
Online Access: | |
Collection: | Henry Stewart Talks - Collection details see MPG.ReNa |
Table of Contents:
- The oligomer cascade hypothesis for Alzheimer's Disease
- Why the oligomer hypothesis has largely supplanted the amyloid cascade hypothesis
- The role of AβOs in memory failure and the major facets of AD neuropathology
- Mechanisms by which AβOs instigate neurotoxicity
- Why AβOs accumulate in the first place
- How AβOs offer superb targets for novel AD diagnostics and disease-modifying therapeutics
- Beside its direct link to Alzheimer's disease, the discovery of toxic Aβ oligomers has provided a novel structural archetype for toxins germane to more than two dozen diseases of protein mis-folding, including Diabetes, Parkinson's, and prion diseases